1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,006 | 0,008 | 09.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.12.25 | SoftOx Solutions AS: Danish Medicines Agency Approves Phase 2a Trial for SoftOx Inhalation Solution | - | Oslo Børs | ||
| 18.12.25 | SoftOx Solutions AS: Financial calendar | 3 | Oslo Børs | ||
| 15.12.25 | SoftOx Solutions AS: Minutes from the Extraordinary General Meeting | 2 | Oslo Børs | ||
| SOFTOX SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 05.12.25 | SoftOx Solutions AS: New Share Capital | 1 | Oslo Børs | ||
| 28.11.25 | SoftOx Solutions AS: Notice of Extraordinary General Assembly | - | Oslo Børs | ||
| 28.11.25 | SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited | - | Oslo Børs | ||
| 26.11.25 | SoftOx Solutions AS: Third Quarter Report 2025 | - | Oslo Børs | ||
| 14.11.25 | SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured - Key Milestone for CF and EDF Clinical Programs | - | Oslo Børs | ||
| 16.10.25 | SoftOx Solutions AS: SoftOx submits Phase 1 Clinical Trial Application under the European Defence Fund Program | - | Oslo Børs | ||
| 13.10.25 | SoftOx Solutions AS: New Share Capital | 1 | Oslo Børs | ||
| 03.10.25 | SoftOx Solutions AS: New Share Capital | 8 | Oslo Børs | ||
| 01.10.25 | SoftOx Solutions AS: Clinical Trial Application for Dose Escalation / Cystic Fibrosis Phase 2a - Important Milestone Achieved | - | Oslo Børs | ||
| 25.09.25 | SoftOx Solutions AS: Clarification on Placement Commission | - | Oslo Børs | ||
| 25.09.25 | SoftOx Solutions AS: Private Placements resolved | 1 | Oslo Børs | ||
| 23.09.25 | SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough | 4 | Oslo Børs | ||
| 17.09.25 | SoftOx Solutions AS: Second Quarter/Half-Year Report 2025 | 1 | Oslo Børs | ||
| 11.09.25 | SoftOx Solutions AS: Softox Solutions AS exercises on the financing facility with Long State Investments Limited | 11 | Oslo Børs | ||
| 08.09.25 | SoftOx Solutions AS: Presentation Deck and link to today's Investor Update | 1 | Oslo Børs | ||
| 08.09.25 | SoftOx Solutions AS: Reminder - Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment | 1 | Oslo Børs | ||
| 03.09.25 | SoftOx Solutions AS: Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment | - | Oslo Børs |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,510 | -0,04 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,500 | +1,26 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| FRESENIUS | 49,230 | -1,05 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| BETA BIONICS | 20,550 | -35,76 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,620 | -3,74 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,260 | -1,01 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| PROGYNY | 26,990 | -1,64 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| GERRESHEIMER | 27,400 | +0,37 % | Bechtle, Gerresheimer, HelloFresh, Kontron, Lanxess, TUI - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,755 | -0,93 % | Where Alignment Healthcare Stands With Analysts | ||
| CLEARPOINT NEURO | 14,950 | -2,35 % | ClearPoint Neuro schließt Zustimmungsvereinbarung zur Restrukturierung von IRRAS AB | ||
| GENEDX | 135,54 | -1,32 % | GeneDx partners with Komodo Health to create comprehensive rare disease dataset | ||
| PROCEPT BIOROBOTICS | 32,840 | -4,76 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| LUMEXA IMAGING | 16,840 | -5,02 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| INTELLIGENT BIO SOLUTIONS | 18,055 | +24,43 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| HEARTFLOW | 33,200 | -0,81 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen |
SOFTOX SOLUTIONS AS gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +24,00 % bei einem Aktienkurs von 0,006 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SOFTOX SOLUTIONS AS finden Sie auf Wallstreet Online.